131 related articles for article (PubMed ID: 5577484)
1. Glucose, insulin, and free fatty acid metabolism in Parkinson's disease treated with levodopa.
Van Woert MH; Mueller PS
Clin Pharmacol Ther; 1971; 12(2):360-7. PubMed ID: 5577484
[No Abstract] [Full Text] [Related]
2. Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism.
Sirtori CR; Bolme P; Azarnoff DL
N Engl J Med; 1972 Oct; 287(15):729-33. PubMed ID: 5056733
[No Abstract] [Full Text] [Related]
3. Abnormal insulin secretion in Parkinson's disease before and during L-dihydroxyphenylalanine (L-dopa) therapy.
Van Woert MH; Mueller PS; Ambani LM; Rathey U
J Endocrinol; 1973 Dec; 59(3):523-34. PubMed ID: 4761683
[No Abstract] [Full Text] [Related]
4. Glucose kinetics and fatty acids in dogs on matched insulin infusion after glucose load.
Vranic M; Fono P; Kovacevic N; Lin BJ
Metabolism; 1971 Oct; 20(10):954-67. PubMed ID: 5097683
[No Abstract] [Full Text] [Related]
5. Effects of long-term L-dopa therapy on carbohydrate metabolism in patients with Parkinson's disease.
Rosati G; Maioli M; Aiello I; Farris A; Agnetti V
Eur Neurol; 1976; 14(3):229-39. PubMed ID: 1278195
[TBL] [Abstract][Full Text] [Related]
6. Decreased insulin production, elevated growth hormone levels, and glucose intolerance in liver disease.
Hernandez A; Zorrilla E; Gershberg H
J Lab Clin Med; 1969 Jan; 73(1):25-33. PubMed ID: 5762161
[No Abstract] [Full Text] [Related]
7. [Glucose tolerance, insulin secretion, levels of free fatty acids and growth hormone in hepatic cirrhosis].
Marañón A; Durán S; Sanjose G; Romero E
Rev Clin Esp; 1974 Feb; 132(4):299-306. PubMed ID: 4831267
[No Abstract] [Full Text] [Related]
8. [Aging and pancreatic secretion].
Kosaka K; Haguro R; Odagiri R
Horumon To Rinsho; 1969 Oct; 17(10):863-9. PubMed ID: 5390547
[No Abstract] [Full Text] [Related]
9. Sebum-excretion rate and skin-surface lipid composition in Parkinson's disease before and during therapy with levodopa.
Cotterill JA; Cunliffe WJ; Williamson B; Arrowsmith WA; Cook JB; Sumner D
Lancet; 1971 Jun; 1(7712):1271-2. PubMed ID: 4104720
[No Abstract] [Full Text] [Related]
10. Amantadine enhancement of L-DOPA induced growth hormone stimulation.
Massara F; Camanni F; Molinatti GM
Horm Metab Res; 1973 Nov; 5(6):454-6. PubMed ID: 4767002
[No Abstract] [Full Text] [Related]
11. Influence of fenfluramine on insulin and growth hormone secretion.
Cabezas-Cerrato J; Casanueva F; Villanueva L; Gómez M; Camarero E
Arch Farmacol Toxicol; 1978 Aug; 4(2):227-36. PubMed ID: 727835
[No Abstract] [Full Text] [Related]
12. Plasma growth hormone and insulin response to levodopa and amantadine.
Kytömäki O; Nousiainen R; Pekkarinen A; Rinne UK; Viljanen M
J Neural Transm; 1973; 34(2):145-51. PubMed ID: 4722572
[No Abstract] [Full Text] [Related]
13. [Normal behavior of glucose tolerance, insulin secretion and free fatty acids under carbohydrate load in childhood].
Amendt P; Michaelis D; Gottschling D; Hildmann W
Endokrinologie; 1974 Sep; 63(3):373-80. PubMed ID: 4470085
[No Abstract] [Full Text] [Related]
14. Effects of medroxyprogesterone acetate on serum insulin and growth hormone levels in diabetics and potential diabetics.
Gershberg H; Zorrilla E; Hernandez A; Hulse M
Obstet Gynecol; 1969 Mar; 33(3):383-9. PubMed ID: 5776088
[No Abstract] [Full Text] [Related]
15. Influence of long term growth hormone therapy on glucose tolerance and insulin secretion.
Zuppinger KA; Joss EE
Acta Paediatr Scand; 1971 Nov; 60(6):678-84. PubMed ID: 5123497
[No Abstract] [Full Text] [Related]
16. Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.
Fenderson RW; Sekowski I; Mohan C; Deutsch S; Benjamin F; Samuel P
Am J Clin Nutr; 1974 Jan; 27(1):22-8. PubMed ID: 4809201
[No Abstract] [Full Text] [Related]
17. Plasma insulin response during oral glucose tolerance tests in newborns of normal and gestational diabetic mothers.
Pildes RS; Hart RJ; Warrner R; Cornblath M
Pediatrics; 1969 Jul; 44(1):76-83. PubMed ID: 5795407
[No Abstract] [Full Text] [Related]
18. [Insulin secretion in obese patients with thyroideal hypofunction and post-climatacteric state].
Durán García S; Marañoń Cabello A; Gómez López A; Romero Bobillo E; Zurro Hernández J; Romero E
Rev Clin Esp; 1973 Nov; 131(4):307-12. PubMed ID: 4589593
[No Abstract] [Full Text] [Related]
19. [Influence of therapy on glucose and lipid metabolism as well as insulin secretion in diabetes mellitus].
Lohmann D; Verlohren HJ; Pohl A; Brückner U
Dtsch Z Verdau Stoffwechselkr; 1976; 36(2):77-84. PubMed ID: 1017406
[No Abstract] [Full Text] [Related]
20. [Effect of L-dopa on pituitary hormones and on carbohydrate and fat metabolism in normal persons and in patients with Parkinsonism].
Geser CA; Müller-Hess R; Dufresne JJ; Felber JP; Vannotti A
Schweiz Med Wochenschr; 1973 May; 103(19):690-7. PubMed ID: 4703913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
